Good Manufacturing Practices, or GMP’s, are well known for people in the medical device and pharmaceutical industries. Many people, however, are unaware of how critical a role they play in other consumer product industries such as cosmetics. The cosmetics industry is unique in that cosmetics are FDA regulated, but not FDA approved. The FDA defines cosmetics as any products that are intended to cleanse, beautify, or alter appearance.[1] So, if the FDA does not approve these products, how can they regulate them and what does that entail?

The FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA). The main purpose of these two laws is to ensure that cosmetic products are made and labeled in a way that is safe for public health. The FD&C act considers the following situations adulterations of cosmetics, and consequently could initiate an enforcement action against a manufacturer:

  • The cosmetic product contains any poisonous substance
  • There is dirt, decomposed, or otherwise extraneous material in the product
  • The product was prepared, packed, or held under unsanitary conditions
  • The product’s container is composed of poisonous substances
  • The product contains unsafe color additives or other substances

Misbranding is also a major concern for cosmetics manufacturers, as the FDA considers any violation of the FD&C Act and FPLA a criminal offense. In short, although cosmetics do not require any sort of premarket approval from the FDA, they are still heavily regulated and require robust GMP’s. Additionally, cosmetic manufacturers should be maintaining and documenting all of their controls via their Quality Management System (QMS).

There has been a noticeable uptick in cosmetic products hitting the shelves in the past year or so, bringing more attention to the industry from the FDA. EMMA International’s team of FDA compliance experts has successfully helped cosmetic manufacturers implement GMP’s and maintain compliance, without putting an overdue burden on their organization. Give us a call at 248-987-4497 or email info@emmainternational.com to see how we can help your organization today!

[1] FDA (n.d.) Cosmetics Overview retrieved on 10/26/2021 from: https://www.fda.gov/industry/regulated-products/cosmetics-overview#:~:text=The%20FDA%20defines%20a%20cosmetic,attractiveness%2C%20or%20altering%20the%20appearance.

Madison Green

Madison Green

Director of Technical Operations - Mrs. Green serves as EMMA International’s Director of Technical Operations. She has experience in technical writing, nonconforming product management, issue evaluations, and implementing corrective and preventative actions in the pharmaceuticals and medical device industries. She has experience cross-functionally between R&D, lean manufacturing operations, and RA compliance. Mrs. Green also has academic and work experience with human health-risk engineering controls, physiological biophysics, and clinical research. Mrs. Green holds a Bachelor of Science in Biosystems Engineering with a concentration in Biomedical Engineering from Michigan State University. She is also a Certified Quality Auditor (CQA), and is currently pursuing her M.S. in Quality Management.

More Resources

The 10 Golden Rules for GMP Production – Part 1

The 10 Golden Rules for GMP Production – Part 1

Good Manufacturing Practices (GMP) is a system that consists of processes, procedures and documentation that ensures products are consistently produced and controlled according to set quality standards; for pharmaceutical production this is especially important. In general, there are 10 golden rules that apply in order to fulfill the GMP requirements. This article is part 1 of a 2-part series that discusses the first 5 rules and why they are important.
The eSTAR 510k

The eSTAR 510k

The voluntary eSTAR (electronic Submission Template And Resource) is a fillable portable document format (PDF) document that seeks to make 510(k) and De Novo submissions quicker and easier due to its automation from its form construction and autofill capability
Medical Device Reporting

Medical Device Reporting

Medical device reporting (MDR) is one of the post market surveillance tools used by the FDA to monitor medical devices’ performance post release (21 CFR part 803)

Ready to learn more about working with us?

Pin It on Pinterest

Share This